ASX ANNOUNCEMENT 17 September 2026 Radiopharm Theranostics Limited Suite 1, Level 3, 62 Lygon Street, Carlton South VIC 3053 Australia ABN: 57 647 877 889 Not for release to US wire services or distribution in the United States Share purchase plan completed Sydney, Australia – Thursday,...
Share purchase plan completed
Filed with ASX ·
6ix hasn’t read this filing yet.
Radiopharm Theranostics Limited on 6ix
Earlier from Radiopharm Theranostics
- Radiopharm Theranostics Selected for Late-Breaking Oral Presentation of Positive Data from Interim Analysis of U.S. Phase 2b Imaging Trial of RAD101 at 2026 Society of Neuro-Oncology Annual Meeting
- RAD oral presentation at SNO26 on RAD101 Phase IIb data
- Results of Meeting
- Radiopharm Theranostics Announces Positive Data from the Phase 1 Imaging Trial of RAD301 in Patients with Pancreatic Ductal Adenocarcinoma
- RAD Announces Positive Data from RAD301 P1 Imaging Trial
Later from Radiopharm Theranostics
- Application for quotation of securities - RAD
- RADOC New Class Options Range of Units and Top 20 Holders
- Notification regarding unquoted securities - RAD
- Change of Director's Interest Notices x 4
- Annual Report and Form 20-F
Follow Radiopharm Theranostics into a list and get an email when it puts out news.
Follow Radiopharm Theranostics